Anaphylaxis Risk Prompts Nationwide Recall of BREXAFEMME® Tablets JERSEY CITY, N.J., September 27, 2023 — SCYNEXIS, Inc. has initiated a voluntary recall spanning the entire nation for two lots of BREXAFEMME® (ibrexafungerp tablets) at the consumer level in the U.S. The recall arises due to concerns of potential cross … [Read more...] about Brexafemme Anaphylaxis Lawsuit Lawyers